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Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These tu-
mors tend to present most frequently in the stomach, followed by the small intestine. GISTs can also arise from the omen-
tum, retroperitoneum, mesentery, or pleura and are termed extragastrointestinal stromal tumors (EGISTs) when they do 
so. EGISTs arising from the omentum are very rare. Due to the limited incidence of EGISTs in the omentum, the diagnostic 
criteria are not well established, and making a correct diagnosis may be difficult. In this report, we present a case of an 
EGIST of the omentum with peritoneal metastasis that was initially suspected to be an appendiceal mucinous carcinoma 
with carcinomatosis on positron emission tomography/computed tomography imaging.
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INTRODUCTION
Gastrointestinal stromal tumors (GISTs) are rare and account for 
only 2.0% of all gastrointestinal neoplasms [1]. GISTs are the most 
common mesenchymal tumors of the gastrointestinal tract. The 
most commonly involved site is the stomach, followed by the 
small intestine [2]. GISTs can be identified as a distinct subset by 
using c-kit (CD 117) which is positive in almost all GISTs [3]. 
Histologically, GISTs are known to originate from precursors of 
the interstitial cells of Cajal [4]. In rare examples, GISTs can also 
arise from the omentum, retroperitoneum, mesentery, or pleura, 
and they are categorized as extragastrointestinal stromal tumors 
(EGISTs) [5]. EGISTs of the omentum are rare. Due to the limited 
incidence of EGISTs in the omentum, an accurate diagnosis 
might be somewhat difficult to make preoperatively. We experi-
enced a case of an EGIST of the omentum with peritoneal metas-
tasis that was initially suspected to be an appendiceal mucinous 
carcinoma with carcinomatosis.
CASE REPORT
A 54-year-old male was admitted to the emergency room with 
right lower quadrant (RLQ) abdominal pain. He had a history of 
hypertension and diabetes mellitus and was being treated at an 
outpatient clinic with regular medications. In addition, he had 
chronic kidney disease. On physical examination in the emergency 
room, his body temperature was 36.8°C, his heart rate was 86 per 
minute, his blood pressure was 186/113 mmHg, and his respira-
tory rate was 18 per minute. Diffuse lower abdominal pain of the 
right-abdomen was noted. On laboratory examination, the white 
blood cell count was 6,490 cells/mm3 (segment form, 57.6%) and 
the blood chemistry was abnormal: blood urea nitrogen (BUN), 
29.8 mg/dL; creatinine (Cr), 1.68 mg/dL; lipase, 113U/L; and tro-
ponin T, 0.035 mcg/L. Tumor markers, such as carcinoembryonic 
antigen and carbohydrate antigen 19–9, were within normal 
ranges.
Because of the patient’s history of chronic renal disease and the 
elevated BUN/Cr level at initial examination, an abdominopelvic 
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computed tomography (CT) was performed without contrast me-
dia. The CT revealed heterogeneous soft tissue lesions in the RLQ 
with an embedded appendix and multiple nodules in the omen-
tum, mesentery, and pelvis. However, the results were inconclu-
sive due to the lack of contrast enhancement. On a contrast-en-
hanced abdominopelvic CT performed after the recovery of renal 
function with hydration, loculated cystic and solid masses mea-
suring up to 7 cm were noted in the RLQ, and the appendix was 
invisible. Multiple seeding nodules were observed in the greater 
omentum, subhepatic space, bilateral paracolic, mesentery, pelvis, 
and rectal shelf, with a moderate number of malignant ascites. 
However, no gross primary mass was seen in the gastrointestinal 
tract or the pancreas. 
On a F-18 fluorodeoxyglucose positron emission tomography/
computed tomography (FDG PET/CT) scan to evaluate systemic 
dissemination, an approximately 7.3-cm hypermetabolic mass 
with a focal cystic portion was seen in the retrocecal area, and 
other large hypermetabolic masses with cystic portions were also 
seen in the pelvic cavity. Multiple hypermetabolic foci and omen-
tal cakes were noted along the peritoneum and the greater omen-
tum, with a large number of ascites (Fig. 1). Accordingly, the most 
probable preoperative radiologic diagnosis was an appendiceal 
mucinous carcinoma with peritoneal seeding.
Surgery with curative intent was performed, and numerous cys-
tic nodules were found in the whole peritoneum, but mainly in 
greater omentum. The appendix was grossly normal. A curative 
R0 resection was not possible due to the dissemination of multiple 
small cystic masses in the whole abdominal cavity. Only a partial 
resection of the greater omentum, the excision of a large cystic 
mass located in the RLQ area, and an appendectomy were per-
formed with a palliative aim (Fig. 2).
The pathologic diagnosis was a malignant GIST, and mitosis 
was up to 7/10 high power fields, with necrosis showing epitheli-
oid features, hemorrhage and cystic degeneration. Immunohisto-
chemically, the tumor cells were positive for C-kit, vimentin, syn-
aptophysin and S-100, but negative for CD34, α-smooth muscle 
A B
Fig. 2. Surgical specimen. (A) Variously-sized multiple grape-like nodules were detected in the greater omentum. (B) The appendix with peri-
toneal seeding nodules. The appendix itself showed no abnormal findings.
A B C
Fig. 1. Positron emission tomography/computed tomography findings. (A) A hypermetabolic mass with a focal cystic portion in the retrocecal 
area (white arrow). (B, C) Multiple hypermetabolic foci and omental cakes along the peritoneum and greater omentum (white arrow, respec-
tively).
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actin (SMA), and myeloperoxidase (Fig. 3).
After the diagnosis of a malignant GIST, additional studies, such 
as a small bowel series, esophagogastroduodenoscopy, and colo-
noscopy, were done to find the primary site. However, no primary 
suspected mass or abnormal finding was seen on those examina-
tions. Imatinib mesylate (Gleevec, Novartis, Basel, Switzerland) 
was started for further adjuvant treatment.
DISCUSSION
In this case, we found innumerable grape-like omental nodules 
during exploration [5]. Although locating the epicenter of the pri-
mary large tumor was difficult, we believe that the gastrointestinal 
tract might not have been the origin of the disease because we 
could not find any abnormal manifestations in the bowel walls on 
esophagogastroduodenoscopy, colonoscopy, or the small bowel 
series. In addition, pathologic examination revealed that the cystic 
masses were surrounded by omental tissues, not by gastrointesti-
nal wall tissue. Two masses in the RLQ of the abdomen, which 
were detected on the preoperative PET/CT, were not derived from 
any kind of gastrointestinal tract, mesentery or retroperitoneum. 
For this reason, we determined our patient as having an EGIST 
arising from the omentum.
Primary GISTs have been reported to be hypervascular and het-
erogeneous because of necrosis, hemorrhage, and cystic degener-
ation [6]. CT is a useful diagnostic tool in the localization of a 
GIST. Typical CT findings of a GIST have been reported to in-
clude central fluid attenuation and heterogeneity of the soft tissue 
attenuation [7]. The CT findings of a primary GIST in the omen-
tum and mesentery are known to be well-marginated, lobulated 
masses containing large areas of low attenuation without central 
gas [8]. However, the CT features of GISTs can be variable, de-
pending on the tumor’s location, size, and malignant potential [9].
PET/CT is an emerging tool for treatment response evaluation, 
as well as diagnosis, in various tumors and has been used in esti-
mating treatment response in GIST patients [10, 11].  In addition, 
PET/CT is known to be able to predict the malignant potential of 
a GIST [12]. As far as we know, no typical findings of EGISTs in 
PET-CT examinations have been reported so far. 
In the current case, the preoperative diagnosis was an appendi-
ceal mucinous neoplasm with carcinomatosis. In evaluating dis-
seminated mucinous carcinomas, PET imaging has inherent limi-
tations because hypocellular tumors usually have low FDG uptake 
and that leads to a low sensitivity [13]. PET results have been re-
ported to be positive in 35% of all cases and even in patients with 
high-grade disseminated cancer of the appendix; the sensitivity 
was only 41% [14]. In contrast, another study reported that PET 
imaging could detect peritoneal metastatic lesions of a mucinous 
adenocarcinoma of the appendix because the FDG uptake was 
influenced by mitotic activity, tumor grade, Ki 67 index, and so 
on [15]. In our case, an invisible appendix with large cystic masses 
in the RLQ of the abdomen prevented an accurate diagnosis on 
the preoperative PET/CT examination. Extensive multiple seed-
ing nodules in the whole abdomen, including the greater omen-
tum, and associated with a moderate number of ascites were be-
lieved to be the aggravation of peritoneal disseminations of a mu-
cinous neoplasm. In addition, no enlarged lymph nodes were 
seen in the peritoneum or retroperitoneum.
Miettinen et al. [5] reported the clinicopathological features of 95 
cases of GISTs presenting with omental masses. Although they did 
not confine their report to pure omental GISTs and included some 
tumors attached to the gastrointestinal tract, the 95 cases were di-
vided into solitary omental GISTs and multiple omental GISTs. 
The positivity rates of KIT, CD34, and SMA were 93%, 61%, and 
32%, respectively, in solitary omental GISTs and were 95%, 33%, 
and 14%, respectively, in multiple omental GISTs. Immunohisto-
chemical staining of our case revealed positive signals for c-KIT 
and negative signals for CD34 and SMA. In the survival analysis of 
the Miettinen et al. [5] ’s study the median survival for multiple 
omental GISTs was reported to be 8 or 9 months, showing a poorer 
prognosis than solitary omental GISTs. We should mention that 
the patients in the above study did not receive any kind of imatinib 
treatment. The clinical impact of using adjuvant imatinib to treat 
multiple omental GISTs requires further investigation.
In conclusion, an EGIST is an uncommon disease and is diffi-
cult to diagnose by imaging alone. However, this disease might be 
A B C D
Fig. 3. Pathologic examinations. (A) Partly spindling and predominantly epitheliod tumor cells, hematoxylin-eosin stain (×100). (B) Epitheli-
oid tumor cells and tripolar mitosis, hematoxylin-eosin stain (×400). (C) C-kit diffuse cytoplasmic expression (×200). (D) CD34 negative in 
tumor cells, only positive in the endothelial cells of blood vessels (×200).
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included as one of the differential diagnoses of patients with mul-
tiple cystic lesions and seeding nodules along the mesentery and 
peritoneum and with an unknown primary tumor. 
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